$280.06
0.41% yesterday
NYSE, May 05, 10:06 pm CET
ISIN
US0311621009
Symbol
AMGN
Sector
Industry

Amgen Stock price

$280.06
-9.63 3.32% 1M
-39.23 12.29% 6M
+19.42 7.45% YTD
-19.42 6.48% 1Y
+45.71 19.51% 3Y
+43.70 18.49% 5Y
+120.62 75.65% 10Y
NYSE, Closing price Mon, May 05 2025
-1.16 0.41%
ISIN
US0311621009
Symbol
AMGN
Sector
Industry

Key metrics

Market capitalization $150.57b
Enterprise Value $199.15b
P/E (TTM) P/E ratio 25.56
EV/FCF (TTM) EV/FCF 18.25
EV/Sales (TTM) EV/Sales 5.87
P/S ratio (TTM) P/S ratio 4.44
P/B ratio (TTM) P/B ratio 24.26
Dividend yield 3.21%
Last dividend (FY24) $9.00
Revenue growth (TTM) Revenue growth 15.59%
Revenue (TTM) Revenue $33.93b
EBIT (operating result TTM) EBIT $8.91b
Free Cash Flow (TTM) Free Cash Flow $10.92b
Cash position $8.81b
EPS (TTM) EPS $10.95
P/E forward 21.13
P/S forward 4.28
EV/Sales forward 5.66
Short interest 2.71%
Show more

Create a Free Account to create an Amgen alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Amgen Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Amgen forecast:

13x Buy
41%
16x Hold
50%
3x Sell
9%

Analyst Opinions

32 Analysts have issued a Amgen forecast:

Buy
41%
Hold
50%
Sell
9%

Financial data from Amgen

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
33,929 33,929
16% 16%
100%
- Direct Costs 11,050 11,050
11% 11%
33%
22,879 22,879
18% 18%
67%
- Selling and Administrative Expenses 2,309 2,309
8% 8%
7%
- Research and Development Expense 6,081 6,081
20% 20%
18%
14,489 14,489
22% 22%
43%
- Depreciation and Amortization 5,580 5,580
22% 22%
16%
EBIT (Operating Income) EBIT 8,909 8,909
22% 22%
26%
Net Profit 5,933 5,933
58% 58%
17%

In millions USD.

Don't miss a Thing! We will send you all news about Amgen directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Amgen Stock News

Positive
Seeking Alpha
one day ago
Amgen reported strong Q1 results with a 9% YoY revenue increase and a 24% rise in operating EPS, but shares dipped due to risk-on market sentiment. Despite competitive pressures and softer EPS trends, Amgen remains undervalued with a high dividend yield of 3.39% and robust free cash flow. Key risks include emerging therapies and macroeconomic factors, but positive Phase III data and new product...
Positive
Seeking Alpha
3 days ago
Verizon is the only Dow Dog meeting the ideal of annual dividends from $1K invested exceeding the single share price, supported by adequate free cash flow. Analyst projections suggest top Dow Dogs could net gains between 21.02% and 45.17% by May 2026, with an average net gain of 32.18%. 28 of 30 current Dow-listed stocks pay dividends. As of 5/1/25, the top ten ranged from 2.64%-6.26% by annual...
Neutral
MarketBeat
4 days ago
In today's unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those that don't rely too heavily on international markets.
More Amgen News

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Head office United States
CEO Robert Bradway
Employees 28,000
Founded 1980
Website www.amgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today